07WL47Z
Revision Cisterna Chyli to No Qualifier with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | 7 Lymphatic and Hemic Systems |
| Operation | W Revision |
| Body Part | L Cisterna Chyli |
| Approach | 4 Percutaneous Endoscopic |
| Device | 7 Autologous Tissue Substitute |
| Qualifier | Z No Qualifier |
Operation Definition
Correcting, to the extent possible, a portion of a malfunctioning device or the position of a displaced device
Procedure Overview
Revision procedures address a device that was previously placed in the lymphatic and hemic system and is no longer working as intended or has moved out of position, and the surgeon corrects the problem without fully removing and replacing the device. In practice this arises with implanted devices used to manage lymphatic complications, such as a clip or mechanical closure device placed around the thoracic duct that has slipped, loosened, or otherwise failed to control a chyle leak as originally intended. Repositioning or adjusting that device to restore its function falls into this family.
Because implanted lymphatic devices are uncommon compared to those used elsewhere in the body, this family is used less frequently than Revision families in other body systems, but the clinical logic is the same: correct what exists rather than start over.
Anatomy & Axis Detail
Cisterna Chyli
Revision of the cisterna chyli involves correcting a malfunctioning or malpositioned device placed during a prior procedure on this retroperitoneal lymphatic reservoir, such as an occlusion coil or plug that has shifted, failed to seal a leak, or produced a new obstruction to lymphatic drainage. Because the cisterna lies deep between the aorta and the vertebral bodies at roughly the L1-L2 level, revision is almost always performed percutaneously under fluoroscopic guidance rather than through direct surgical exposure. Clinical indications include recurrent chylous ascites or chylothorax despite an initial restriction or occlusion attempt, or device-related complications identified on follow-up lymphangiography. Documentation should distinguish revision, which corrects an existing device or repair, from a fresh restriction or occlusion procedure targeting a new site along the lymphatic pathway.
Approach: Percutaneous Endoscopic
Percutaneous Endoscopic combines a puncture through skin or mucous membrane with insertion of an endoscope to visualize the procedure internally, as in laparoscopic cholecystectomy. It is distinguished from plain Percutaneous by the presence of scope-guided visualization, and from Via Natural or Artificial Opening Endoscopic by its route being a new puncture rather than an existing orifice or stoma.
Device: Autologous Tissue Substitute
Autologous Tissue Substitute identifies a device value where material harvested from the patient's own body, such as an autograft, is used to replace or reconstruct a body part. Its defining feature is tissue origin from the patient, setting it apart from Nonautologous Tissue Substitute, sourced from a donor or animal, and Synthetic Substitute, made of manufactured material.
Coding & Documentation
A coder should confirm the note describes fixing or repositioning a device that was already in place, rather than removing it entirely and inserting a new one. Documentation needs to identify both the device being revised and the specific problem being corrected, such as displacement or malfunction. The most common error is coding Removal followed by a fresh insertion when the surgeon actually adjusted the existing device in place, which should be captured as a single Revision instead.